- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
11 result(s) found for: Betahistine.
Displaying page 1 of 1.
EudraCT Number: 2008-001840-38 | Sponsor Protocol Number: BET207 | Start Date*: 2008-08-05 | |||||||||||
Sponsor Name:OBEcure | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Female Subjects | |||||||||||||
Medical condition: obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002474-52 | Sponsor Protocol Number: AM-125-CL-18-01 | Start Date*: 2019-04-01 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: Multicenter randomized controlled phase 2 trial to evaluate AM-125 in the treatment of acute peripheral vertigo following neurosurgery (TRAVERS) | |||||||||||||
Medical condition: Treatment of acute peripheral vertigo | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) PL (Completed) DE (Completed) GB (GB - no longer in EU/EEA) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005246-42 | Sponsor Protocol Number: 0796-19 | Start Date*: 2021-12-28 | ||||||||||||||||
Sponsor Name:INTAS PHARMACEUTICALS LIMITED | ||||||||||||||||||
Full Title: A Multicenter, Three- arm, Double- blind, Double dummy, Parallel-group, placebo controlled Study for efficacy and safety evaluation of prolonged release formulation of Betahistine PR 48 mg once dai... | ||||||||||||||||||
Medical condition: Menière´s disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005122-33 | Sponsor Protocol Number: NIMOBET-1 | Start Date*: 2014-03-04 | |||||||||||
Sponsor Name:MDM S.p.A. | |||||||||||||
Full Title: A phase II, randomized, double-blind, parallel groups study to assess the efficacy and safety of Nimodipine 20 mg + Betahistine 16 mg versus Placebo + Betahistine 16 mg in the treatment of vertigo | |||||||||||||
Medical condition: Vertigo | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000885-21 | Sponsor Protocol Number: BETA | Start Date*: 2008-03-25 | |||||||||||
Sponsor Name:TNO | |||||||||||||
Full Title: The effect of betahistine 48 mg three times daily on motion sickness | |||||||||||||
Medical condition: This study will evaluate the impact of betahistine on motion sickness. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013702-14 | Sponsor Protocol Number: BETNV009 | Start Date*: 2010-08-13 | ||||||||||||||||
Sponsor Name:Hospital of the University of Munich | ||||||||||||||||||
Full Title: Effects of betahistine on central vestibular compensation in acute unilateral vestibular failure: a double-blind, placebo-controlled trial | ||||||||||||||||||
Medical condition: vestibular failure (vestibular neuritis) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-004025-27 | Sponsor Protocol Number: Antivert1-B09_PE_V1.0 | Start Date*: 2013-02-15 | |||||||||||||||||||||||||||||||
Sponsor Name:HENNIG ARZNEIMITTEL GmbH & Co. KG | |||||||||||||||||||||||||||||||||
Full Title: Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride 16 mg in patients with vertigo of peripheral origin. A multi-centre, double-b... | |||||||||||||||||||||||||||||||||
Medical condition: Vertigo of peripheral origin | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: AT (Completed) CZ (Completed) BG (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-000444-13 | Sponsor Protocol Number: X16012008 | Start Date*: 2008-04-08 | |||||||||||
Sponsor Name:Finnish Defence Forces | |||||||||||||
Full Title: Äkillisen akustisen vamman hoito ylipaineisella happihoidolla ja lääkkeillä: Prospektiivinen satunnaistettu ja kontrolloitu tutkimus vamman saaneilla varusmiehillä. | |||||||||||||
Medical condition: Acustic or barotraumas after gun accident in conscripts | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000752-32 | Sponsor Protocol Number: 04T-617 | Start Date*: 2006-01-23 | |||||||||||
Sponsor Name:Klinikum Grosshadern | |||||||||||||
Full Title: Medical treatment of Menière’s disease with betahistine: a placebo-controlled, dose-finding study | |||||||||||||
Medical condition: Ménière’s disease is a disorder of the inner ear membranous labyrinth characterized by paroxysmal vertiginous attacks, fluctuating sensorineural hearing loss, aural fullness, and tinnitus .The unde... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001337-86 | Sponsor Protocol Number: 104-201403 | Start Date*: 2014-07-11 | |||||||||||
Sponsor Name:Otonomy Inc. | |||||||||||||
Full Title: A 6-month, prospective, randomized, multicenter, placebo-controlled safety study of OTO-104 given at 3-month intervals by intratympanic injection in subjects with unilateral Meniere's disease, foll... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001464-35 | Sponsor Protocol Number: 104-201811 | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:Otonomy, Inc. | |||||||||||||
Full Title: A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 3 efficacy and safety study of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere’... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
